The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Surgical Innovations confirms CE mark certification for 'CELLIS' range

Thu, 13th Sep 2018 10:06

(Sharecast News) - Innovative medical technology designer and manufacturer Surgical Innovations Group updated the market on the CELLIS range of products supplied to its UK distribution business, Elemental Healthcare, by Meccellis Biotech on Thursday.The AIM-traded firm said that on 12 September, Elemental received confirmation from Meccellis that CE certification had been issued in respect of the full range of CELLIS products previously sold by Elemental, and also covering new products including the CELLIS Breast Pocket range launched at the London Breast meeting on 6 & 7 September 2018.It said the certificates were valid until August 2023."Meccellis are now in a position to resume manufacture of these products, and detailed plans are in progress to facilitate a timely and controlled reintroduction to the UK market in coming weeks," the Surgical Innovations board said in its statement.

Related Shares

More News
18 Apr 2024 16:52

LONDON MARKET CLOSE: Stocks recover some of recent Fed talk losses

(Alliance News) - Stock prices in London closed up on Thursday, despite the prospect of higher for longer US interest rates hanging over stocks, while...

18 Apr 2024 10:49

AIM WINNERS & LOSERS: Surgical Innovations up as revenue jumps

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

18 Apr 2024 10:47

Surgical Innovations sets sights on future growth after record revenue

(Alliance News) - Shares in Surgical Innovations Group PLC rose on Thursday, as the company released its results for the past year and announced the s...

9 Apr 2024 13:44

Surgical Innovations confirms CFO Charmaine Day's departure

(Alliance News) - Surgical Innovations Group PLC on Tuesday confirmed that Charmaine Day has stepped down as its finance chief.

9 Apr 2024 09:30

AIM WINNERS & LOSERS: Tern rises on Talking Medicines quarterly update

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.